JMCC Group is the leading provider of premium Jamaican medical cannabis products and services to the world. Founded in 2016 and headquartered in Toronto, Canada and Montego Bay, Jamaica, we are a fully integrated, global medical cannabis company. Our self-contained supply chain – from propagation and cultivation of raw material supply to product development, manufacturing, packaging and distribution – enables us to manage every step to meet or exceed the highest international standards for quality, security and sustainability.
From the start, our vision has focused on supplying patients everywhere with the highest quality medical products – all made from JMCC’s own GMP- and Organic-certified cannabis, sustainably grown, at an affordable price point.
JMCC Source combines Jamaica’s ideal, year-round growing climate and unique cannabis varieties with an unswerving commitment to meeting or exceeding international quality, safety and security standards. We are compliant with GACP and EU GMP standards and “Certified Organic” (North America) with certifications pending.
Today JMCC Scientific is developing safe, best-in-class, liquid cannabis medicine products, based on evidentiary science and formulated to assist patients with specific medical conditions. Our innovative, nano-emulsified oral sprays have been developed to simplify titration by prescribers, self-administration by patients and consistency throughout treatment.
JMCC Distribution provides for complete chain-of-command tracking from warehouse to end-customer delivery. Our medical cannabis products – and those of our distribution-services clients – reach customers, research partners and patients worldwide safely, securely, on time and cost effectively.
Further National Health-Service Information on